Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "Prenatal Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Prenatal Diagnostics Market to Reach $14.2 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Prenatal Diagnostics estimated at US$4.7 Billion in the year 2022, is projected to reach a revised size of US$14.2 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2022-2030. Non-Invasive, one of the segments analyzed in the report, is projected to record 18.3% CAGR and reach US$10.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Invasive segment is readjusted to a revised 7.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 20.8% CAGR
The Prenatal Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 20.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 12.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.
Select Competitors (Total 43 Featured) -
- ANGLE Plc
- Berry Genomics Co. Ltd.
- BGI Genomics
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Illumina Inc.
- Laboratory Corporation of America Holdings
- Lifecodexx AG
- Natera Inc.
- Quest Diagnostics Inc.
- Ravgen Inc.
- Sequenom Inc.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 194 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value (USD) in 2020 | $4 Billion |
| Forecasted Market Value (USD) by 2027 | $9.3 Billion |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Prenatal Testing: An Introductory Prelude
- Recent Market Activity
- The Rationale for Prenatal Genetic Testing
- Steady Growth Projected Over the Coming Years for Prenatal Testing
- Developed Regions: Primary Revenue Contributors
- Fast Paced Growth Forecasts in Developing Regions
- Northbound Trajectory in Healthcare Spending Creates Conducive Environment
- Prevailing Economic Scenario Favors Increased Healthcare Spending
- Progressive Momentum in Med Tech Sector Generates Parallel Opportunities
- Prenatal Diagnostics - Global Key Competitors Percentage Market Share in 2023 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape
- Major Factors Influencing Penetration of NIPT
- NIPT Eliminates Risks & Uncertainty of Conventional Procedures
- Replacing Screening Tests - A More Conceivable Change through NIPT
- Diversity in NIPT Usage on the Cards
- Benefits Outweigh Snags in NIPT Tests
- Whole Genome Sequencing Technology in NIPT
- DNA - More Ideal Target for NIPT Analysis than Whole Cells
- Conventional Invasive Techniques Loose Sheen
- Chromosomal Abnormalities Lead the Prenatal Testing Space
- Chromosomal Abnormalities - A Substantial Economic Burden
- List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
- Significant Opportunities in Down's Syndrome Testing
- List of Select Screening Tests Available for T21 Screening and Confirmation
- Beyond Down's Syndrome - Need to Test Additional Targets Crucial
- Trisomy 18 or Edward's Syndrome
- Trisomy 13 or Patau Syndrome
- Cystic Fibrosis Screening and Diagnosis
- Cystic Fibrosis Screening Market - Highly Fragmented
- ACOG and ACGM Recommendations Boost Demand for Prenatal CF Testing
- Prenatal Testing Crucial to Detect Risk of Huntington's Disease
- Increasing Congenital Disorder Incidence - Key Driver for Prenatal Diagnostics
- Prenatal Testing - Effective Way of Alleviating Syphilis Related Deaths and Stillbirths
- Molecular Diagnostics Widen Scope & Span of Prenatal Testing
- NGS & MPS - Enabling Shorter Time to Test Results
- Microarray-Based Prenatal Testing Gathers Steam
- Sequencing in Prenatal Testing - A Potential High Growth Market
- Ultrasound - An Indispensable Combination with Blood Based Screening Tests
- New Sub-Targets on the Anvil for Ultrasound-Based Screening
- Counseling - An Imperative Measure Before and After Prenatal Testing
- Role of Prenatal Testing in Managing Preterm Births
- Lower Sensitivity & Specificity of Existing Tests - A Case for New Tests on the Anvil
- High Sensitivity Serum Tests May Not Have Many Takers
- Ballooning Global Female Population Offers Increased Growth Opportunities
- Issues & Challenges
- Prenatal Diagnostics: Treading Sensitive Ethical Issues
- Controversy Related to "Incidental Findings" of Prenatal Tests
- Opposition to NIPT Technique - A Significant Hurdle to Adoption
- Unresolved Issues Hamper Widespread Testing for Monogenetic Disease
- Dearth of Genetic Counselors - A Major Hurdle for Genetic Testing
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
A selection of companies mentioned in this report includes
- ANGLE Plc
- Berry Genomics Co. Ltd.
- BGI Genomics
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Illumina Inc.
- Laboratory Corporation of America Holdings
- Lifecodexx AG
- Natera Inc.
- Quest Diagnostics Inc.
- Ravgen Inc.
- Sequenom Inc.
For more information about this report visit https://www.researchandmarkets.com/r/18prpo
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
